NOVO-B.CO vs. ^GSPC

In the year-to-date period, NOVO-B.CO achieves a -26.11% return, which is significantly lower than ^GSPC's 0.12% return. Both investments have delivered pretty close results over the past 10 years, with NOVO-B.CO having a 11.36% annualized return and ^GSPC not far behind at 10.82%.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOVO-B.CO) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current NOVO-B.CO Sharpe Ratio is -1.13, which is lower than the ^GSPC Sharpe Ratio of 0.56. The chart below compares the historical Sharpe Ratios of NOVO-B.CO and ^GSPC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

The maximum NOVO-B.CO drawdown since its inception was -64.64%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for NOVO-B.CO and ^GSPC.

Novo Nordisk A/S (NOVO-B.CO) has a higher volatility of 11.19% compared to S&P 500 (^GSPC) at 4.77%. This indicates that NOVO-B.CO's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.